Lantern Pharma Inc. (LTRN) Stock buybacks 2022–2024
Lantern Pharma Inc. (LTRN) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$499,997FY2024 · since FY2022: $939,666 → $499,997
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $499,997 | -79.9% |
| FY2023 | $2.5M | +164.2% |
| FY2022 | $939,666 | — |
Source: SEC XBRL filings · For reference only · Not investment advice